Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
LNTH Lantheus Holdings, Inc. daily Stock Chart
LNTH [NASD]
Lantheus Holdings, Inc.
Healthcare | Diagnostics & Research | USA
statements
Index- P/E44.80 EPS (ttm)0.30 Insider Own1.90% Shs Outstand66.81M Perf Week3.84%
Market Cap886.35M Forward P/E14.36 EPS next Y0.94 Insider Trans-9.43% Shs Float65.55M Perf Month-14.31%
Income11.60M PEG2.50 EPS next Q0.03 Inst Own67.80% Short Float3.48% Perf Quarter17.14%
Sales331.80M P/S2.67 EPS this Y-23.00% Inst Trans6.87% Short Ratio3.06 Perf Half Y-19.61%
Book/sh11.95 P/B1.13 EPS next Y79.77% ROA2.20% Target Price21.00 Perf Year-36.48%
Cash/sh1.38 P/C9.82 EPS next 5Y17.90% ROE5.50% 52W Range8.67 - 27.12 Perf YTD-34.03%
Dividend- P/FCF20.56 EPS past 5Y51.00% ROI16.70% 52W High-50.11% Beta1.08
Dividend %- Quick Ratio1.90 Sales past 5Y2.90% Gross Margin47.40% 52W Low56.06% ATR0.65
Employees508 Current Ratio2.40 Sales Q/Q-23.00% Oper. Margin6.80% RSI (14)43.07 Volatility3.57% 4.78%
OptionableYes Debt/Eq0.44 EPS Q/Q-202.00% Profit Margin3.50% Rel Volume0.52 Prev Close13.53
ShortableYes LT Debt/Eq0.41 EarningsJul 30 BMO Payout0.00% Avg Volume744.81K Price13.53
Recom2.00 SMA20-7.03% SMA50-5.84% SMA200-15.18% Volume388,327 Change0.00%
Jun-29-20Resumed Jefferies Buy $29
Aug-16-19Upgrade CJS Securities Market Perform → Market Outperform
Nov-02-17Upgrade Wells Fargo Market Perform → Outperform
Nov-08-16Reiterated RBC Capital Mkts Outperform $6 → $12
Sep-23-16Resumed Credit Suisse Neutral
Feb-24-16Reiterated RBC Capital Mkts Outperform $9 → $6
Dec-11-15Downgrade Credit Suisse Outperform → Neutral
Sep-30-15Downgrade Wells Fargo Outperform → Market Perform
Jul-20-15Initiated Wells Fargo Outperform
Jul-20-15Initiated Robert W. Baird Outperform $10
Jul-20-15Initiated RBC Capital Mkts Outperform $10
Jul-20-15Initiated Jefferies Buy $12
Jul-20-15Initiated Credit Suisse Outperform $10
Aug-12-20 08:00AM  
Lantheus Holdings, Inc. Announces FDA Approval of VIALMIX® RFID Device for DEFINITY®
Business Wire
Jul-30-20 12:00PM  
Lantheus Holdings Inc (LNTH) Q2 2020 Earnings Call Transcript
Motley Fool -6.75%
07:00AM  
Lantheus Holdings, Inc. Reports Second Quarter 2020 Financial Results
Business Wire
Jul-29-20 03:06PM  
Here's What Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Shareholder Ownership Structure Looks Like
Simply Wall St.
Jul-28-20 10:25AM  
Did Hedge Funds Make The Right Call On Lantheus Holdings Inc (LNTH) ?
Insider Monkey
Jul-23-20 08:00AM  
Lantheus Holdings to Host Second Quarter 2020 Earnings Conference Call on July 30, 2020 at 8:00 a.m. Eastern Time
Business Wire
Jul-01-20 08:00AM  
Lantheus Holdings to Showcase the Potential of PyL Imaging Agent at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 Annual Meeting
Business Wire
Jun-22-20 12:11PM  
Lantheus Holdings Inc (LNTH): Hedge Funds Are Adding
Insider Monkey -5.73%
07:00AM  
Lantheus Completes Merger with Progenics
Business Wire
Jun-17-20 05:33PM  
Independent Bank Group Set to Join S&P SmallCap 600
PR Newswire
Jun-16-20 04:05PM  
Lantheus Stockholders Approve Share Issuance For Merger with Progenics
Business Wire
08:30AM  
Lantheus Holdings to Present at the BMO 2020 Prescriptions for Success Virtual Healthcare Conference
Business Wire
May-27-20 07:53PM  
SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.
PR Newswire +8.14%
May-20-20 04:30PM  
Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference
Business Wire
May-05-20 04:30PM  
Lantheus Holdings to Present at the UBS Virtual Global Healthcare Conference
Business Wire
May-01-20 07:31PM  
Edited Transcript of LNTH earnings conference call or presentation 30-Apr-20 12:00pm GMT
Thomson Reuters StreetEvents -7.51%
Apr-30-20 06:30PM  
Lantheus Holdings Inc (LNTH) Q1 2020 Earnings Call Transcript
Motley Fool -6.99%
07:39AM  
Recap: Lantheus Holdings Q1 Earnings
Benzinga
07:00AM  
Lantheus Holdings, Inc. Reports First Quarter 2020 Financial Results
Business Wire
Apr-16-20 08:30AM  
Lantheus Holdings to Host First Quarter 2020 Earnings Conference Call on April 30, 2020 at 8:00 a.m. Eastern Time
Business Wire
Apr-14-20 11:17AM  
ADDING MULTIMEDIA Velan Capital Agrees to Support Merger of Lantheus and Progenics
Business Wire
Apr-09-20 08:30AM  
Lantheus Holdings, Inc. Reports Preliminary Q1 Revenue Near Top End of Previously Disclosed Guidance Range; Withdraws 2020 Financial Guidance
Business Wire
Apr-06-20 08:30AM  
Lantheus Holdings, Inc. to Hold 2020 Annual Meeting of Stockholders Virtually
Business Wire +7.25%
Apr-04-20 10:15AM  
How Does Lantheus Holdings's (NASDAQ:LNTH) P/E Compare To Its Industry, After The Share Price Drop?
Simply Wall St.
Apr-02-20 02:58PM  
Boston Scientific cuts exec pay as revenue slides
American City Business Journals
08:30AM  
Lantheus and Progenics Reschedule Their Respective Special Meetings of Stockholders for Proposed Merger
Business Wire
Mar-17-20 07:58AM  
A Sliding Share Price Has Us Looking At Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/E Ratio
Simply Wall St. +9.09%
Feb-28-20 07:06AM  
Edited Transcript of LNTH earnings conference call or presentation 25-Feb-20 1:00pm GMT
Thomson Reuters StreetEvents
Feb-27-20 02:10PM  
Lantheus Holdings, Inc. Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Simply Wall St.
Feb-26-20 09:36AM  
The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates
Benzinga
Feb-25-20 07:00AM  
Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results
Business Wire
06:00AM  
Lantheus Holdings, Inc. to Host Earnings Call
ACCESSWIRE
Feb-24-20 02:18PM  
Are Lantheus Holdings, Inc.s (NASDAQ:LNTH) High Returns Really That Great?
Simply Wall St.
Feb-21-20 07:46AM  
The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
Benzinga
Feb-20-20 11:30AM  
Lantheus and Progenics Agree to Amended Transaction Terms
Business Wire
Feb-18-20 09:00AM  
Lantheus Holdings to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Business Wire
08:30AM  
Lantheus Holdings to Host Fourth Quarter and Full Year 2019 Earnings Conference Call on February 25, 2020 at 8:00 a.m. Eastern Time
Business Wire
Feb-03-20 08:30AM  
Lantheus Announces Topline Results for BENEFIT 1 LVEF Clinical Trial
Business Wire
Jan-28-20 09:27AM  
Does The Lantheus Holdings, Inc. (NASDAQ:LNTH) Share Price Fall With The Market?
Simply Wall St.
Jan-27-20 08:30AM  
Lantheus Holdings Announces Senior Leadership Appointment
Business Wire
Jan-13-20 08:30AM  
Lantheus Holdings Announces Senior Leadership Appointment
Business Wire -5.84%
Jan-02-20 02:24PM  
Should You Worry About Lantheus Holdings, Inc.'s (NASDAQ:LNTH) CEO Pay Cheque?
Simply Wall St. -6.14%
Dec-13-19 12:53PM  
Is Lantheus Holdings Inc (LNTH) Going to Burn These Hedge Funds?
Insider Monkey
Dec-09-19 12:57PM  
Is It Too Late To Consider Buying Lantheus Holdings, Inc. (NASDAQ:LNTH)?
Simply Wall St.
08:00AM  
Lantheus Enters into Strategic Collaboration with CarThera for Use of Microbubbles in Combination with SonoCloud® System for Treatment of Glioblastoma
Business Wire
Nov-21-19 04:05PM  
Lantheus Holdings to Present at the 31st Annual Piper Jaffray Healthcare Conference
Business Wire
Nov-12-19 12:29PM  
Is Lantheus Holdings, Inc. (NASDAQ:LNTH) A High Quality Stock To Own?
Simply Wall St.
Nov-07-19 08:12AM  
Lantheus Releases Comprehensive Strategic Plan for Progenics
Business Wire
Nov-01-19 01:14AM  
Edited Transcript of LNTH earnings conference call or presentation 31-Oct-19 12:00pm GMT
Thomson Reuters StreetEvents
Oct-31-19 08:55AM  
Lantheus Holdings (LNTH) Tops Q3 Earnings and Revenue Estimates
Zacks
07:00AM  
Lantheus Holdings, Inc. Reports Third Quarter 2019 Financial Results
Business Wire
Oct-29-19 04:30PM  
Lantheus Holdings to Present at the Credit Suisse 28th Annual Healthcare Conference
Business Wire
Oct-28-19 02:00PM  
Progenics Strongly Agrees With ISS Recommendation that Velan Group SHOULD NOT Get Majority Control of the Board of Directors
GlobeNewswire
Oct-27-19 06:39PM  
Here is What Hedge Funds Think About Lantheus Holdings Inc (LNTH)
Insider Monkey
Oct-24-19 10:32AM  
Lantheus Holdings (LNTH) Earnings Expected to Grow: Should You Buy?
Zacks
Oct-23-19 09:55AM  
Progenics Highlights Additional Serious Concerns About Velan Capital, L.P.
GlobeNewswire
07:26AM  
What Is Lantheus Holdings's (NASDAQ:LNTH) P/E Ratio After Its Share Price Tanked?
Simply Wall St.
Oct-17-19 04:05PM  
Lantheus Holdings to Host Third Quarter 2019 Earnings Conference Call on October 31, 2019 at 8:00 a.m. Eastern Time
Business Wire
Oct-16-19 10:16AM  
If You Had Bought Lantheus Holdings (NASDAQ:LNTH) Stock Three Years Ago, You Could Pocket A 125% Gain Today
Simply Wall St.
Oct-11-19 03:20PM  
Progenics Pharmaceuticals Needs a Treatment for Sickly Corporate Governance
CorpGov.com
Oct-08-19 04:11PM  
SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, PGNX, DOVA Shareholders About Its Ongoing Investigations
GlobeNewswire
Oct-04-19 06:14PM  
SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.
PR Newswire
07:30AM  
Possible M&A Surrounds These 3 Stocks
TheStreet.com
Oct-03-19 10:52AM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Progenics Pharmaceuticals, Inc. to Lantheus Holdings, Inc. is Fair to Shareholders
GlobeNewswire
Oct-02-19 03:12PM  
Lantheus To Acquire Progenics Pharma In All-Stock Deal
Benzinga -20.77%
02:25PM  
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Progenics Pharmaceuticals, Inc.
PR Newswire
08:33AM  
Progenics's stock drops after all-stock buyout deal, as acquirer Lantheus's shares plunge
MarketWatch
07:08AM  
Lantheus to Acquire Progenics to Form a Leading Precision Diagnostics Imaging and Therapeutics Company
Business Wire
Sep-26-19 02:14PM  
Is Lantheus Holdings (NASDAQ:LNTH) Using Too Much Debt?
Simply Wall St.
Sep-06-19 07:48AM  
Why We Like Lantheus Holdings, Inc.s (NASDAQ:LNTH) 19% Return On Capital Employed
Simply Wall St.
Sep-05-19 07:15PM  
Lantheus Holdings Inc (LNTH) President & CEO Mary Anne Heino Sold $541,661 of Shares
GuruFocus.com
Aug-22-19 04:05PM  
Lantheus Holdings to Present at the Wells Fargo Securities 2019 Healthcare Conference
Business Wire
Aug-17-19 07:56AM  
Does Lantheus Holdings, Inc. (NASDAQ:LNTH) Have A Good P/E Ratio?
Simply Wall St.
Jul-31-19 01:39AM  
Lantheus Holdings Inc (LNTH) Q2 2019 Earnings Call Transcript
Motley Fool
Jul-29-19 07:02PM  
Edited Transcript of LNTH earnings conference call or presentation 25-Jul-19 12:00pm GMT
Thomson Reuters StreetEvents
Jul-28-19 10:04AM  
Is Lantheus Holdings, Inc. (NASDAQ:LNTH) Trading At A 29% Discount?
Simply Wall St.
Jul-25-19 08:55AM  
Lantheus Holdings (LNTH) Q2 Earnings Match Estimates
Zacks -20.15%
07:30AM  
Lantheus Holdings, Inc. Reports Second Quarter 2019 Financial Results
Business Wire
Jul-18-19 10:33AM  
Lantheus Holdings (LNTH) Earnings Expected to Grow: Should You Buy?
Zacks
Jul-13-19 07:28AM  
These 6 stocks in the S&P 1500 have more than doubled in 12 months
MarketWatch
Jul-11-19 04:05PM  
Lantheus Holdings to Host Second Quarter 2019 Earnings Conference Call on July 25, 2019 at 8:00 a.m. Eastern Time
Business Wire
Jul-08-19 12:07PM  
Is Lantheus Holdings, Inc.'s (NASDAQ:LNTH) CEO Being Overpaid?
Simply Wall St.
Jun-24-19 09:00AM  
Lantheus Announces Presentation of New Patient Outcomes Data for DEFINITY® at the American Society of Echocardiography 2019 Annual Scientific Sessions
Business Wire
Jun-20-19 04:15PM  
Lantheus Announces New Patient Outcomes Data for DEFINITY® to be Presented at the American Society of Echocardiography 2019 Annual Scientific Sessions
Business Wire
Jun-19-19 06:38PM  
Here is What Hedge Funds Think About Lantheus Holdings Inc (LNTH)
Insider Monkey
Jun-11-19 11:46AM  
Is It Time To Consider Buying Lantheus Holdings, Inc. (NASDAQ:LNTH)?
Simply Wall St.
May-30-19 05:00PM  
Lantheus Announces Strategic Collaboration with NanoMab to Provide a Novel Biomarker for Clinical Development and Management of Immuno-Oncology Therapies
Business Wire
May-22-19 04:05PM  
Lantheus Holdings, Inc. to Present at the Jefferies 2019 Global Healthcare Conference
Business Wire
May-08-19 02:27PM  
Heres What Hedge Funds Think About Lantheus Holdings Inc (LNTH)
Insider Monkey
10:23AM  
Does Market Volatility Impact Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Share Price?
Simply Wall St.
May-07-19 04:05PM  
Lantheus Holdings, Inc. to Present at the 2019 UBS Global Healthcare Conference
Business Wire
May-01-19 11:08PM  
Edited Transcript of LNTH earnings conference call or presentation 30-Apr-19 12:00pm GMT
Thomson Reuters StreetEvents
Apr-30-19 01:49PM  
Lantheus Holdings Inc (LNTH) Q1 2019 Earnings Call Transcript
Motley Fool
08:45AM  
Lantheus Holdings (LNTH) Q1 Earnings Top Estimates
Zacks
07:39AM  
Lantheus Holdings: 1Q Earnings Snapshot
Associated Press
07:00AM  
Lantheus Holdings, Inc. Reports First Quarter 2019 Financial Results
Business Wire
Apr-19-19 09:30AM  
LNTH vs. CLPBY: Which Stock Is the Better Value Option?
Zacks
Apr-16-19 04:05PM  
Lantheus Holdings to Host First Quarter 2019 Earnings Conference Call on April 30, 2019 at 8:00 a.m. Eastern Time
Business Wire
Apr-15-19 12:37PM  
Is Lantheus Holdings, Inc. (NASDAQ:LNTH) A High Quality Stock To Own?
Simply Wall St.
Apr-04-19 06:00AM  
Two Health Favorites- Wound Care to Medical Imaging
MoneyShow
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases worldwide. Its principal products include DEFINITY, a microbubble contrast agent used in ultrasound exams of the heart; and TechneLite, a technetium generator that provides the nuclear material used in nuclear medicine procedures. The company also offers Xenon, a radiopharmaceutical gas used to assess pulmonary function, and to image cerebral blood flow; Neurolite, an injectable to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable technetium-labeled imaging agent used in myocardial perfusion imaging (MPI) procedures; FDG, a fluorine-18-radiolabeled imaging agent to identify and characterize tumors in patients undergoing oncologic diagnostic procedures; and Cobalt (Co 57), a non-pharmaceutical radiochemical. In addition, it provides injectable radiopharmaceutical imaging agents, such as Thallium TI 201, which is used in MPI studies to detect cardiovascular disease; Gallium Ga 67 that is used to detect various infections and cancerous tumors; and Quadramet, a therapeutic product, which is used to treat severe bone pain associated with metastatic bone lesions. Further, the company is developing Flurpiridaz F 18, which is in Phase III clinical trials to assess blood flow to the heart; and LMI 1195 that is in Phase III clinical trials for the diagnosis and treatment follow-up of neuroendocrine tumors. It sells its products to radiopharmacies, integrated delivery networks, hospitals, clinics, and group practices. The company has a strategic collaboration and license agreement with NanoMab Technology Limited to provide an imaging biomarker research tool to pharmaceutical companies and academic centers conducting research and development on PD-L1 immuno-oncology treatments. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Heino Mary AnnePresident & CEOJul 23Sale16.023,00048,051604,793Jul 27 04:30 PM
Heino Mary AnnePresident & CEOJul 15Sale16.0122,125354,254607,793Jul 17 04:30 PM
Bolla John J.Chief Operations OfficerJun 16Sale14.292,42234,60360,419Jun 18 04:30 PM
DUFFY MICHAEL PSVP and General CounselApr 28Sale13.137,19894,529133,402Apr 30 06:35 PM
Heino Mary AnnePresident & CEOApr 27Sale13.7730,033413,407634,318Apr 29 04:30 PM
DUFFY MICHAEL PSVP and General CounselMar 06Sale14.581,93628,229140,600Mar 10 04:30 PM
Heino Mary AnnePresident & CEOMar 05Sale15.359,019138,408664,351Mar 05 04:31 PM
Marshall Robert J. Jr.CFO and TreasurerFeb 28Sale15.4588913,73150,993Mar 02 04:34 PM
Heino Mary AnnePresident & CEOFeb 27Sale16.0525,000401,288524,399Feb 28 04:32 PM
Marshall Robert J. Jr.CFO and TreasurerFeb 27Sale15.791,54624,40751,882Mar 02 04:34 PM
Bolla John J.Chief Operations OfficerFeb 27Sale15.791,25119,75035,154Mar 02 04:33 PM
McHugh JulieDirectorFeb 27Sale15.861,75627,84515,754Mar 02 04:34 PM
LENO SAM RDirectorFeb 27Sale15.852,70042,79235,372Mar 02 04:32 PM
DUFFY MICHAEL PSVP and General CounselFeb 27Sale15.791,55224,501116,493Mar 02 04:30 PM
Robertson A FrederickDirectorFeb 27Sale15.862,66042,19340,402Mar 02 04:30 PM
Heino Mary AnnePresident & CEOFeb 26Sale17.096,615113,031549,399Feb 28 04:32 PM
Heino Mary AnnePresident & CEOFeb 24Sale16.069,898158,970556,014Feb 26 04:30 PM
Heino Mary AnnePresident & CEODec 20Sale20.8519,260401,602563,034Dec 23 04:30 PM
Marshall Robert J. Jr.CFO and TreasurerDec 16Sale20.826,351132,22853,428Dec 18 04:31 PM
LENO SAM RDirectorDec 13Sale20.3011,508233,55538,072Dec 17 04:31 PM
DUFFY MICHAEL PSVP and General CounselNov 14Sale20.797,500155,925123,890Nov 18 04:30 PM
Marshall Robert J. Jr.CFO and TreasurerOct 16Sale19.074,80991,69859,779Oct 18 04:30 PM
Heino Mary AnnePresident & CEOSep 20Sale25.8115,590402,448582,294Sep 24 04:30 PM
DUFFY MICHAEL PSVP and General CounselSep 12Sale23.747,500178,028131,390Sep 16 04:30 PM
DUFFY MICHAEL PSVP and General CounselSep 04Sale20.605,604115,465138,890Sep 06 04:30 PM
Heino Mary AnnePresident & CEOSep 03Sale21.2125,538541,679597,884Sep 05 04:30 PM
open in yahoo | open in reuters | open in google